Regional Sites Contact Us ORAL DOSE BIOLOGICS SPECIALTY CLINICAL SUPPLY CONSUMER EXPERT CONTENT LOCATIONS ABOUT US CAREERS Home » Expert Content BROWSE BY SITES: BIOLOGICS CLINICAL SUPPLY SERVICES CONSUMER HEALTH TOPICS: VIEW ALL DEVELOPMENT & BIOAVAILABILITY DOSE FORM DESIGN ORAL TECHNOLOGIES SOFTGEL TECHNOLOGIES ORAL MANUFACTURING SMALL MOLECULE ANALYTICAL INHALATION SMALL MOLECULE INJECTABLE TYPE: VIEW ALL ARTICLE / WHITEPAPER BROCHURE CASE STUDY EBOOK EXECUTIVE SUMMARY INFOGRAPHIC OFFERING FACT SHEET POSTER PRESENTATION VIDEO WEBINARS Outsourcing Pharma Manufacturing – Keys to Successful Technology Transfers This article discusses a systematic approach to ensure tech transfers meet scheduled timelines. View Now Overcoming Manufacturing Challenges for Accelerated Drug Development This executive summary provides expert insight on overcoming manufacturing challenges associated with expedited development programs. View Now Maintaining Drug Product Properties and Optimizing Late-Stage Manufacturing Efficiency Summary: In this webinar, experts provide an overview of the latest trends in manufacturing of oral solid dosage form and discuss key considerations of transitioning an early-stage project to late-stage as well as technology transfer. View Now Mapping the Pathway to Designing Successful Treatments This executive summary includes evidence on how the right guidance at the right time can help you create more successful treatments. View Now Highly Potent API Drug Product Development and Manufacturing Using Micronization Technology Summary: This webinar will discuss how to classify HPAPIs in early development and share recommendations for safe product handling, from clinical manufacturing to commercialization. View Now Micronization Technology Solutions From Early Phase Development to Commercial Scale Manufacturing Summary: Catalent is a global leader in pharmaceutical air jet milling micronization with more than 30 years’ experience delivering micronization solutions. View Now Concept to Dosing-Challenges in New Orphan Drugs Summary: In this webinar a group of experienced cancer drug developers discusses key strategies in managing an orphan drug program. View Now A Guide to Drug Development of Challenging Molecules Summary: This webinar discusses, key considerations of early drug development, molecule developability assessment, drug bioavailability and discussed the relationship between intracellular and transcellular permeability of beyond the Rule of Five drugs. View Now Inhalation-Nasal Delivery Technology, Quality by Design Processes and Outsourcing Considerations Catalent leverages decades of experience in the development, evaluation and manufacture of inhalation products to advance and accelerate molecules, from early development through commercial manufacturing. View Now Using Zydis® ODT to Solve Delivery Challenges for Tolerogenic Vaccines Summary: Using Zydis® orally dissolving tablet (ODT) platform from Catalent as a unique delivery route for allergy immunotherapies. View Now Proven Quality – Preventing Quality Issues During Drug Development Summary: A growing number of drug launches have faltered at the final hour because manufacturing processes weren’t up to FDA standards. This webinar explores how drug developers can properly monitor quality throughout the clinical production process and fix any issues that arise—before the FDA brings out the red flags. View Now Biologics By Mouth-Leveraging Freeze-Dried Orally Disintegrating Tablets Summary: Learn more about the role of oral dose delivery for tolerogenic vaccines, fast dissolving tablets and biological APIs. View Now Scale Up & Tech Transfer of Fluid Bed Coating Processes Summary: This webinar provides an introduction and comparison of top-spray and bottom-spray fluid bed coating technologies and how to select the most appropriate technique to meet the target product profile. View Now Is My Molecule Suitable for an Orally Disintegrating Tablet? Summary: While new drug products may benefit from ODT formulation beginning with product launch, ODT formulation can also play a role in life cycle management of approved products. View Now Effective Scale-Up and Technology Transfer Strategies for Spray Dried Pharma Products Summary: In this webinar, learn from real world case studies about best practices and strategies to mitigate risks and ensure a successful tech transfer from development through to commercial scale spray drying of pharmaceutical products. View Now Pharmaceutical Outsourcing for Oral Development and Manufacturing Summary: This eBook includes an overview of outsourcing trends in the oral solid dose market. Featured articles describe the robust market resulting from the demand for specialized dosage forms such as controlled release, pediatric and geriatric delivery vehicles. View Now OptiForm® Solution Suite Bio Capabilities Sheet OptiForm® Solution Suite Bio is designed to rapidly screen biomolecules’ potential for a non-invasive delivery route. View Now Article: Industry Trend: Examining the Emergence of Unit- & Bi-Dose Nasal Sprays Summary: Molecules that are limited by a slow onset of action, a suboptimal side-effect profile, or a complicated administration process, may be good candidates for adaptation to a unit- or… View Now Orally Inhaled & Nasal Drug Delivery – An Evolving Pipeline Creating New Opportunities Catalent’s Carla Vozone discusses the significant inhalation trends including those in larger molecules and novel indications. View Now Selecting the Most Suitable Dosage Form Technology for the Oral Delivery of Lipid-Based Formulations Summary: Lipid-based drug delivery systems have found widespread acceptance for development of drug products containing developability challenged APIs. View Now Exclusive Orphan Drugs Industry Survey Results Desire to Treat Rare Diseases Tempered by a Lack of Internal Expertise and Capability Summary: Orphan drugs face obstacles that span from discovery to launch, largely because of small patient populations and limited markets for rare disease therapies. View Now OneXpress Solution Capabilities Sheet Summary: OneXpress™ is a single integrated solution that provides the fastest pathway from clinical to commercial manufacturing. View Now Boosting Bioavailability- How Companies are Using Advanced Technologies to Formulate Complex Molecules Summary: This infographic focuses on evolving technologies that help overcome bioavailability challenges enabling the formulation of more complex molecules. View Now OptiDose® Design Solution Capabilities Sheet Summary: OptiDose Design Solution is a comprehensive drug design assessment consisting of a holistic review of the molecule, patient, and market considerations. Led by Catalent’s highly experienced team of scientific advisors, this evaluation assesses key drug design considerations that can help create more successful treatments for all stakeholders. View Now Improving Bioavailability Using PBPK Modeling & Parallel Formulation Screening Read this case study to learn how a team of bioavailability experts at Catalent took a target molecule from early stage to Phase 1 in under nine months. View Now Reducing Inhalation Burden Through High-Dose, Carrier-Free Spray Dry Powders Explore how spray dried particles provide an attractive, carrier-free option for highly dispersed delivery of API to deep lung regions. View Now Zydis® Orally Disintegrating Tablet (ODT) vs. Standard Tablets (ST) Summary: This infographic provides a high level summary of studies comparing Zydis ODT against traditional oral tablets. View Now High Potency Containment from Early Phase to Commercial Scale Micronization Summary: In this webinar, learn more about enabling micronization of potent and highly potent compounds across the different stages of oral drug development View Now Strategies for the Optimal Scale-up & Tech Transfer of Oral Small Molecules Summary: Learn more about how the transition from early to late phase of a small molecule program plays a pivotal role in a program’s ultimate success. View Now Industry Trend: Examining the Emergence of Unit- & Bi-Dose Nasal Sprays Summary: Molecules that are limited by a slow onset of action, a suboptimal side-effect profile, or a complicated administration process, may be good candidates for adaptation to a unit- or… View Now Use of PBPK Modeling for Predicting and Optimizing Controlled Release Dosage Forms Summary: Experts will share how dissolution tools and PBPK modeling can help evaluate whether a molecule is suitable for controlled release applications. View Now Strategies to Optimize the Dosage Form Design Process to Create Better Treatments Summary: Experts use case studies to demonstrate how the right guidance, at the right time, can help drug developers create better treatments. View Now Developing Optimal Formulations Summary: API-sparing development techniques and identification of the appropriate scalable formulation technology to improve drug solubility and enhance oral bioavailability. View Now Integrated Approach to Spray Drying for Optimized Oral and Vaccine Formulations Summary: In this webinar, an academic expert will discuss optimal design space parameters involved in developing spray dried dispersion of poorly soluble drugs for oral and vaccine delivery. View Now Is My Molecule Suitable for an Orally Disintegrating Tablet? Summary: This webinar aims to provide clarity on the types of molecules suitable for an ODT format as well as the regulatory pathways for new and established therapies. View Now Amorphous and Co-Amorphous Systems for Poorly Soluble Drugs Summary: This webinar provides an overview of co-amorphous research and its recent findings, particularly, the impact of low molecular weight excipient on developability, stability and solubility. View Now Importance of Pediatric Biopharmaceutics in Design and Manufacture of Pediatric Dose Forms Summary: Learn about the current challenges in pediatric drug development programs including predicting oral absorption, and in vitro and in silico methods that can be applied to predict behavior in pediatric populations. View Now Accelerate Your Program: Streamlined Phase Appropriate Technologies & Expertise Summary: In this webinar, Catalent experts will explain how the phase appropriate expertise and technologies of the OneXpress™ Solution can help streamline development and manufacturing, speed up your program timelines and reduce risks to transform your science into a successful treatment. View Now What Makes Lipid Excipients So Special? Summary: In this webinar, we explain why a lipid drug development platform can meet the need for speed to clinic and how the innovative lipid excipients and technologies could solve formulation challenges, optimizing bioavailability for early phase molecules, improve patient compliance and bring products faster to market. View Now Getting Your Molecule From Preclinical Dev to Phase I Summary: Three early drug development experts present insights and techniques to help your clients get their molecules from preclinical to Phase 1 studies. View Now A Roadmap for Early Development to Commercial Manufacturing Summary: Phase-appropriate CMC-related activities can facilitate the transition from early development through commercialization. View Now Mapping the Pathway to Designing Successful Treatments Summary: Experts introduce Catalent’s new OptiDose™ Design Solution, an integrated dose form design strategy based on an analyzation of your molecule, patient, and market. View Now Strategies for Integrated Business, Regulatory, & Scientific Needs of CMC Clients Summary: Drug development requires integrating multi-disciplinary business, regulatory and scientific activities. To successfully support a client’s program, it is imperative to provide advice and services that support all three in the context of a program’s goal. In this exclusive webinar presented by Jim Spavins… View Now Catalent’s Expanded Inhalation Offering Summary: Catalent expands its inhalation platform through the acquisition of a Boston-area facility, providing spray drying, powder encapsulation and blister packaging for Dry Powder Inhaler (DPI) capsules. View Now Innovative Solutions to Meet the Complex Pharmaceutical Supply Challenges Summary: Integrated approach from development to clinical and benefits of working with a single integrated provider. View Now Strategies for the Optimal Scale-up & Tech Transfer of Oral Small Molecules Summary: The transition from early phase to late phase of a small molecule program plays a pivotal role in determining a program’s ultimate success. Early planning strategies can help minimize the burdens often faced in that transition. The implementation of modeling tools… View Now Quality by design-Considerations for Inhalation Product Development This article discusses how quality by design (QbD) can be built into inhalation product development to ensure a drug and device are safe and effective. View Now Pharma Predictions for 2021 Catalent CEO John Chiminski to talks about the year ahead, offering projections for what 2021 holds in store for the biopharma industry. View Now From Candidate to Clinic: Strategies to Accelerate Your Molecule’s Development Path The development of orally administered small molecules is more challenging as an many have poor aqueous solubility and bioavailability. View Now Roller Compaction: New Trends, Challenges and Solutions This article discusses why roller compaction is a robust option when developing a tablet or capsule formulation. View Now Strategies for De-risking Early-Phase Oral Small Molecule Drug Development Summary: Characterize lead molecules and develop the best pathway to bring them to Phase I studies and beyond. View Now Partnering for Success: Strategies to Mitigate Common Pitfalls in Early Drug Development Summary: Thousands of drug candidates are abandoned annually due to solubility and bioavailability issues, but advanced formulation technologies can profoundly impact how a drug compound… View Now Early Drug Development: Strategy and Solution This webinar focuses on the key considerations for transitioning small molecules from preclinical through clinical development. View Now From Development to Commercialization: Overcoming Scale-Up Issues Summary: Recorded at Manufacturing Chemist Live 2020, this presentation discusses some of the key issues to consider when planning for the scale-up of a small molecule development program. View Now Analyzing Product Formulation Using Raman Spectroscopy Comparing the dissolution rates and pellet structure of branded Sporanox® with three similar generic products, raman spectroscopy revealed recrystallizing API slowed the dissolution rate. View Now NMR and Mass Spectrometry in Pharmaceutical Development Nuclear Magnetic Resonance spectroscopy and Mass Spectrometry are powerful techniques for the characterization and quantification of compounds. View Now Principles of Raman Spectroscopy and Application to Pharmaceutical Development Raman Spectroscopy is used for applications like polymorph identification, analysis of API form, & evaluation of component distribution within a formulation. View Now Discover the Latest Funding, Drug Development and Clinical Solutions Strategies Summary: Dramatically shifting the attention of the industry, Covid-19 forced orphan developers to re-examine their go-to-market strategies. View Now Derisking Orphan Drug Programs in 2020 and Beyond Summary: Dramatically shifting the attention of the industry, Covid-19 forced orphan developers to re-examine their go-to-market strategies. View Now Developing Optimal Formulations Using Biorelevant Predictive Tools and Advanced Bioavailability Enhancement Technologies Summary: Low bioavailability can lead to development challenges. Advanced formulation expertise and technologies can increase the chance of success in the clinic. View Now Joint Comfort Softgel Summary: Unique combo formula containing LONGVIDA® Curcumin Extract intended to support joint comfort. View Now Cognitive Support Softgel – Unique Supplement Featuring Neumentix™ Spearmint Phenolic Complex Summary: Leveraging Catalent’s expert formulation and dose design capabilities, Kemin Industries has developed a new to the segment nutritional supplement which includes their proprietary phenolic complex Neumentix™ derived from spearmint. View Now Coated Softgels for Consumer Products Summary: With over 80 years of global manufacturing expertise, Catalent has an extensive network of facilities to provide full service integrated softgel manufacturing and coating capabilities. View Now EasyBurst® Chewable Capsules Summary: EasyBurst® chewable technology is an ideal platform to deliver active ingredients, without the need for water, using our advanced taste masked fills encapsulated in our proprietary softgel shells. View Now Softdrop™ Lozenges Summary: SoftDrop™ technology can deliver multiple active ingredients in a single softgel lozenge. View Now Consumer VMS Product Library Summary: As your innovation partner, we will help you address your consumers’ needs by leveraging our differentiated softgel technologies and robust product library to give your brand a competitive advantage in the market. View Now Interview: Fierce Pharma with Jeremie Trochu Summary: Jeremy Trochu, Vice President and General Manager of Pharmaceutical Development Services at Catalent, recently sat down for an interview… View Now Next-Generation Orphan Drug Delivery Summary: Big Pharma used to ignore this segment of the market, but now developing orphan drugs to treat these rare diseases is an industry priority. View Now The Future of Orphan Drugs: Insights on the Current Market, Trends & Strategic Partnerships Driving Innovation Summary: In this report, we will highlight the trends shaping the orphan-drug market, with a particular focus on expedited drug development. Expert insights on navigating development and manufacturing challenges with… View Now OneXpress™: Phase Appropriate Technology & Expertise from Development to Commercialization Summary: OneXpress is a single integrated solution that provides the fastest pathway from clinical development to commercial manufacturing. By taking a proactive approach and assessing production considerations early in development, our teams… View Now Early Phase Solutions Summary: Explore how you can leverage Catalent’s successful track record optimizing thousands of molecules, deep development expertise and broadest set of superior technologies to… View Now Catalent Spray Drying Technology: From Development to Manufacturing Summary: Catalent offers end-to-end spray drying solutions from early-phase development through to clinical supply, and scale-up to commercial finished dose forms. View Now From Candidate to Clinic: Strategies to Accelerate Your Molecule’s Development Path Summary: A fast, efficient development process can deliver the right clinical candidate, best formulation strategy, and optimal dosage form to Phase 1. View Now Strategies to Avoid Dangerous Pitfalls in Pharmaceutical Consulting Summary: Learn the strategies to avoid costly pitfalls in pharmaceutical consulting and Gain inside tips on using CDMO’s to deliver solutions to your clients. View Now Optimizing Lipid-Based Formulation for Commercial Success Summary: This 90-minute virtual workshop includes presentations from BASF and Catalent that demonstrate on how lipid-based drug softgel technology can provide formulators with an effective delivery… View Now Setting Up Your Small Molecule for Success: Formulation, PBPK Modeling and Regulatory Strategies in Early Clinical Trials Summary: This webinar focuses on the key considerations for transitioning small molecules from preclinical through clinical development. View Now Reducing Risks In Early Drug Development: From Drug Candidate to Phase 1 Clinical Testing Summary: Achieving success in early development is essential in progressing a drug molecule’s next milestone. Such pressure can often lead to the adoption of… View Now CMC Considerations for Successful Early Drug Development Summary: This eBook provides insights on key approaches and considerations for preparing your drug development program for long-term success. View Now Phase Appropriate Expertise and Technologies to Accelerate Product Development to Commercialization Summary: In this webinar, pharmaceutical scientists present real-life examples of challenges they’ve overcome in the transfer of oral small molecules from early-phase development to late-phase manufacturing. View Now Preparing Your Drug for Clinical Success: Strategies and Considerations Summary: View this webinar to learn about the key considerations for transitioning a molecule from discovery through clinical studies. View Now Based on Exclusive Survey: Bioavailability Enhancement – Industry Insights, Key Challenges & Advanced Development Solutions Summary: In this webinar, experts present the exclusive survey findings and introduce innovative scalable drug delivery technologies proven to address the industry’s growing need for improving solubility and enhancing bioavailability. View Now R&D Leadership During the Pandemic Summary: R&D execs discuss how they’ve reorganized global teams, tapped new programs to fight COVID-19 and plan for the future after the pandemic. View Now Spray Drying for Bioavailability Enhancement Summary: The use of spray drying to manufacture amorphous dispersions is continuing to grow due to the number of drug candidates exhibiting poor solubility. Nearly 40% of the new chemical… View Now How to Effectively Work with a Development Partner – From a Consultant Standpoint Summary: Hear from experienced industry colleagues on the latest tips that will help your clients avoid critical pitfalls in early development of their drugs to best leverage CDMO… View Now Patient-Focused Drug Design: Through the Lens of Real-World Case Studies, Clinical Evidence and Advanced Delivery Solutions Summary: Join this webinar to discover the current state of patient-focused dose design through clinical evidence, real-world case studies and patient preference-driven drug design solutions that can help develop better treatments and successful real-world outcomes. View Now AAPS 2019: IV Infusion In-Use Compatibility of the Regulatory Hormone Melatonin Summary: The chemical stability challenges associated with many small molecule active pharmaceutical ingredients (API) necessitate the need for parenteral options for drug delivery. View Now Small Molecule Analytical Services Summary: This document provides both a high-level overview of Catalent’s stand-alone small molecule analytical services (on front), and a detailed list of services organized by functional area… View Now Strategies for Flexible Manufacturing Summary: Pharmaceutical and biotechnology companies approach external development and manufacturing partners for solutions for their product’s specific needs. New products are increasingly… View Now Proven Bioavailability Enhancement Solutions for Scalable and Robust Products Summary: Lipid formulation and spray-dried dispersions are widely used, and proven technologies to overcome bioavailability challenges for poorly soluble molecules. For selecting the… View Now How to Accelerate Early Drug Development in Oncology For Small Molecules and Biologics Summary: Get an insight into what it takes to move a pre-clinical drug candidate to a Phase 1 clinical trial. The presentations will provide guidance on non-clinical and regulatory considerations… View Now Spray-Drying Process for Scale up and Commercialization Summary: The use of spray drying to manufacture amorphous dispersions is continuing to grow due to the number of drug candidates exhibiting poor solubility. In a recent Pharmaceutical… View Now Prepare Your Clients for Success: Tips and Strategies to Avoid Dangerous Pitfalls in Consulting Summary: Determining a client’s primary goal is critical to guiding them through the development of their asset. Additionally, their primary focus will impact the strategy used to develop… View Now Rapid Developability Assessment of Early Phase Molecules: Parallel Screening of Enabling Technologies and Use of PBPK Modeling Summary: Achieving success in early development is essential in progressing to your molecule’s next milestone. While solving solubility is a major hurdle to overcome in early development… View Now An Integrated Approach to Spray Drying: From Scale-up to Manufacturing Summary: Spray-drying technology is one of the methods of manufacturing high-quality amorphous solid dispersions. The application of a phase-appropriate quality-by-design… View Now All Offerings Summary: Catalyst + Talent. Our name combines these ideas. From drug and biologic development to delivery technologies and supply solutions, we are the catalyst for your… View Now Designing a Turnkey Orphan Drug Program Summary: This Endpoints News webinar brings four experts who represent some of the key constituencies when developing a modern orphan program – from early research through approval. View Now Model to Predict Process Parameters for Scale-Up of Hot Melt Extrusion Process Summary: Technology transfer and scale-up from a laboratory-scale to commercial-scale HME process require several in-depth empirical studies during product development. Without prior calculations and in-silico scale-up… View Now Planning for Successful Product Launches Summary: There has been increased focus and efforts on developing treatments for diseases with smaller patient populations, diseases for which there are no currently approved treatments… View Now Age-Appropriate Formulation Development for Pediatric Trials: Challenges and Considerations Summary: In this webinar, industry experts discuss the recent advances, challenges and considerations in pediatric drug development. Real-life examples presented by the experts… View Now A Roadmap for Early Development to Commercial Manufacturing Summary: A key hurdle for any drug development program is bringing the drug to clinical studies. Astute companies strategize past this milestone and plan for clinical and regulatory success. View Now Drug Design and the Patient Journey Summary: Patient-focused drug design can be a key factor in real-world therapeutic outcomes and business success. But if successful treatments should be created with patients in mind… View Now Placing Patients at the Center of Drug Design Summary: Patient centricity has always been at the heart of the pharmaceutical industry. With rising costs of drugs and healthcare, there has been an increased focus on the topic. Poor patient acceptance and… View Now Optimizing Spray Drying Strategies for Commercial Pharmaceutical Manufacturing Summary: The use of spray drying to manufacture amorphous dispersions is continuing to grow due to the number of drug candidates exhibiting poor solubility. View Now Solid Dispersions – A Versatile Formulation Strategy for Poorly Soluble Drugs Summary: The influx of poorly soluble compounds into the drug development pipeline is likely to continue unabated. Solid dispersions provide a formulation technique that is… View Now Regulatory Support Summary: Our regulatory team completes over 150 agency submissions each year, supporting all stages of the product lifecycle. We assign a dedicated… View Now About Catalent: More Products. Better Treatments. Reliably Supplied. Summary: Catalyst + Talent. Our name combines these ideas. From drug and biologic development services to delivery technologies to supply solutions, we are the catalyst for your… View Now Catalent: Softgel Encapsulation Summary: Softgel technology is the commercially-proven choice for encapsulation of challenging compounds. In addition, softgel technology may enhance the bioavailability of your product to… View Now Improving Bioavailability with Softgel Technology Summary: Softgel technology offers a number of technical benefits. Probably foremost is the improvement or enhanced bioavailability that’s often achievable with the Softgel dosage… View Now Catalent: A True Strategic Partner Summary: Catalent is much more than just a vendor or a supplier. What we’re trying to provide is a true strategic partnership, to become an extension, if you like, of their organization, and that can… View Now Catalent: Our Commitment To Customers Summary: Catalent’s promise to our customers is more products, better treatments, reliably supplied. That’s not just a tagline for us. Those are the internal behaviors by which we’re trying to live by so that… View Now Catalent: Customizable Innovative Solutions Summary: Catalent is staying on top of innovation maintaining deep and strategic relationships with our customers and our partners. It is critical for Catalent to understand the… View Now Catalent: Integrated Solutions Summary: Our brand is all around more products, better treatments, reliably supplied. In terms of more products, that’s very much around how do — how do we help companies to take more molecules… View Now Catalent: Reliably Supplied Summary: At Catalent, when we talk about “reliably supplied,” it goes way beyond the obvious of making this week’s deliveries on time. It’s about having all the foundational elements in place… View Now Catalent: Why Catalent Summary: Customers work with Catalent because they know that they can come to us and have their most difficult problems solved. They also come to us because there’s no other company out there… View Now Our Values Summary: At Catalent, our culture is entrepreneurial and collaborative. Our employees possess a passion for exceeding customer’s expectations. We are focused on continuous improvement… View Now RP Scherer Softgel Technology for Superior Drug Delivery Summary: As innovators of softgel technology, Catalent RP Scherer softgel brings more than 75 years of development expertise and manufacturing experience to the full spectrum of drug delivery… View Now How to Effectively Work with a Development Partner – From a Consultant Standpoint Summary: Determining a client’s primary goal is critical to guiding them through the development of their asset. Three experienced industry colleagues recently presented on the latest tips… View Now The World’s Leading Pharmaceutical Partner | Now on the NYSE Summary: Whether you are looking for a single, tailored solution or multiple answers throughout your product’s lifecycle, we can improve the total value of your treatment – from discovery… View Now Behind the Scenes: Catalent IPO on the NYSE Summary: On July 31, 2014, Catalent officially listed on the NYSE. Take a look behind the scenes at the NYSE on listing and closing bell day. View Now Catalent Micron Technologies Overview Summary: Micron Technologies adds to Catalent’s long history of innovation and leadership in the pharmaceutical industry, with its proven and versatile portfolio of particle size reduction, micronization and milling… View Now Catalent Micron Technologies A Global Leader in Micronization Services Summary: Catalent Micron Technologies is a leading international provider of particle size reduction and analytical services. We deliver first-class pharmaceutical contract micronization, milling… View Now Potent Capabilities for Micronization Summary: Not only are we able to micronize compounds with air jet mills under full containment, but we have also developed containment solutions for several other types of milling equipment… View Now What is Micronization? Summary: Particle size reduction is achieved through the use of fluid energy jet mills. The material is drawn into a confined, circular chamber by way of pressurized nitrogen gas or compressed… View Now Analytical Services & Capabilities | Why Catalent? Summary: From discovery candidates to clinical trial materials to regulatory submissions to post-approval studies, we offer our partners an extensive array of small molecule analytical… View Now Inhalation Capabilities | Why Catalent? Summary: Catalent combines decades of project with all pulmonary dosage forms including pMDIs, DPIs, nasal sprays and solutions/suspensions for inhalation. Speed is delivered by… View Now RP Scherer Softgel Technology | Why Catalent? Summary: As innovators of softgel technology, Catalent RP Scherer softgel, brings more than 75 years of development expertise and manufacturing experience to the full spectrum… View Now Zydis® Oral Fast Dissolve | Why Catalent? Summary: The Zydis® ODT fast-dissolve formulation, is a unique, freeze-dried oral solid dosage form that disperses instantly in the mouth – no water required. With more than 20 products launched… View Now Orphan Development Capabilities | Why Catalent? Summary: Accelerated regulatory pathways of fast track and breakthrough designations can often shave years off the approval process. Accelerating the development and approval of many drugs is often in everyone’s interest… View Now RP Scherer Softgel Heritage | Why Catalent? Summary: As innovators of softgel technology, Catalent RP Scherer softgel brings more than 75 years of development expertise and manufacturing experience to the full spectrum of drug… View Now Reliably Supplied | Why Catalent? Summary: We have the technology and expertise to take your product from design, to clinical trial, to plant, to pharmacy. Our global network of facilities can provide scalable, cost-effective… View Now Potent Handling Capabilities | Why Catalent? Summary: Catalent is the #1 Drug Development, Delivery and Supply Partner for the global pharmaceutical and biotech industries. With over 20 years of experience in potent handling and more… View Now Catalent Zydis Fast Dissolve Summary: Zydis®, our proprietary fast-dissolve technology, is a unique, freeze-dried oral solid dosage form that disperses instantly in the mouth – no water required. With more than… View Now Softgel Technology to Deliver Poorly Soluble APIs | Catalent in 90 Seconds Summary: The number of poorly soluble new drugs entering development has been estimated to be anywhere from 40% to 70%. Many companies are increasingly focusing their attention on the properties… View Now OptiShell Technology Solves Bioavailability Challenges | Catalent in 90 Seconds Summary: OptiShell™ capsules utilize a patented shell derived from plant polysaccharides that are ideally suited for the encapsulation of higher melting point fill formulations. Soft capsules containing semi-solid… View Now Catalent in 30 Seconds Summary: With over 80 years serving the industry, Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products…. View Now Optimal Drug Delivery Technologies. Better Treatments. Summary: We are your catalyst for creating better treatments. Our deep expertise in drug development, delivery and supply can help improve the bioavailability of your compound, enhance therapeutic profiles… View Now Catalent Corporate Overview Summary: Catalent is the global leader in development, delivery, and supply for pharmaceuticals, biologics, and consumer health products. Integrated analytical and clinical supply services support to… View Now Capacity and global network enables flexible manufacturing Summary: Learn about Catalent’s manufacturing capacity and robust global network. Accredited by 30+ global agencies, it supplies oral, sterile and inhaled products. Catalent has expertise in… View Now Create Patient-centric Dosage Forms with Catalent Summary: A short video on Catalent’s expertise and technologies to help achieve target therapeutic profiles and optimize bioavailability, stability and scalability to create patient-centric… View Now Unlock Your Molecules Potential with Catalent Summary: Your molecule has so much potential, we share the passion to unlock it through extensive expertise and superior formulation technologies. Learn how we have optimized thousands… View Now Bring Pharma, Biopharma and Consumer Health Products to Market with Catalent Summary: A short video on how Catalent can help you develop, deliver, supply better treatments. Whether it is Pharmaceuticals, Biopharmaceuticals, Over-the-Counter, Nutritionals or Beauty Care and Cosmetics, we can… View Now OptiForm® Solution Suite – Fast Track Early Development | Catalent in 90 Seconds Summary: Learn about a Fast, Flexible and Fact-based path for your molecule to progress from late-stage discovery to phase I. View Now Zydis® ODT – Real World Solutions for Patients Summary: Zydis® ODT is an orally dissolving tablet formulated as for fast dissolve that requires little to no water when taking the medication. It provides an ideal dosing solution when dealing… View Now Careers at Catalent Summary: Join us in our mission of bringing better treatments to patients worldwide. Allow our employees to tell you why a career at Catalent could be the right opportunity… View Now Catalent Pharma Solutions – Be Global Summary: Hear how our employees impact people’s lives on a global scale every day. View Now Career Growth and Development at Catalent Summary: Learn from our employees how Catalent helped them grow and develop their careers. View Now Impacting Patient’s Lives Through Operations Careers at Catalent Summary: Meet Cristina, one of our Operations managers, and hear about her experience working at Catalent. View Now Preclinical Techniques for Successful Drug Development Summary: In this video series, P.Y. Chen, Ph.D., of Catalent Pharma Solutions offers insights for accelerating early drug development and mitigating risk. Expert insight… View Now Mitigating Risks During Preclinical Development Summary: In this video series, P.Y. Chen, Ph.D., of Catalent Pharma Solutions offers insights for accelerating early drug development and mitigating risk. An expert’s view on various tools available to… View Now Ensuring Client’s Success in Early Drug Development Summary: In this video series, P.Y. Chen, Ph.D., of Catalent Pharma Solutions offers insights for accelerating early drug development and mitigating risk. Learn how Catalent can…. View Now Join Catalent in Bringing Better Treatments to Patients Worldwide Summary: At Catalent, you will have numerous opportunities to take personal initiative, thrive in a dynamic environment, and make an impact. Allow our employees to tell you about life at Catalent and… View Now Dry Powder Inhaler (DPI) Services at Catalent Summary: Catalent Inhalation provides flexible development and manufacturing solutions for Dry Powder Inhalers (DPIs). View Now Metered Dose Inhaler (MDI) Services at Catalent Summary: Catalent Inhalation provides state-of-the-art development and manufacturing solutions for Metered Dose Inhalers (MDIs). View Now Nasal Spray Manufacture at Catalent Summary: Catalent Inhalation provides robust development and manufacturing solutions for nasal sprays. View Now Overview: Catalent’s Early Talent Programs Summary: Catalent offers numerous opportunities for students and recent grads including Internships, Co-ops, and rotational programs. Learn more! View Now Meet Aileen B. – GOLD Graduate Summary: The Catalent GOLD (Global Organization Leadership Development) Program is a two-year rotational development opportunity… View Now Diversity & Inclusion at Catalent Summary: At Catalent, we foster an environment where individuals are welcomed, appreciated, heard and respected, where differences and similarities are valued. Hear what our employees have to say about… View Now LEARN Employee Resource Group Summary: Catalent strives to foster a diverse and inclusive environment for all employees. Learn more about our LEARN (LGBTQ+ Employees and Allies Resource Network) Employee… View Now Catalent Cares – Erica’s Story Summary: Catalent supports employees who are passianate about a cause or helping the community. Hear how Catalent supported Erica and her team to raise money… View Now Career Development at Catalent Summary: Catalent offers employees numerous opportunities for development and career progression. Hear more about what our team has to say about how Catalent supports their… View Now Product Development Careers at Catalent Summary: Members of our product development eam gain unparalleled experience working on several products using multiple technologies. Hear what it’s like to work… View Now Catalent Cares – Mike’s Story Summary: Catalent encourages employees to make a difference in their local communities. Hear how Mike and his family made a difference for children with special needs at.… View Now Zydis® ODT Consistently Offers Effective Solutions for Sublingual Allergy Immunotherapy Summary: ALK-Abelló A/S is a Denmark-based pharmaceutical company that specializes in the development of immunotherapy products for the treatment of respiratory allergies. ALK partnered with Catalent for… View Now Flexible Manufacturing Strategies: What’s Best For Your Product? Summary: Watch this webinar to get insight from manufacturing experts on the benefits of end-to-end solutions and how flexible manufacturing strategies can accommodate the changing landscape of the pharmaceutical industry. View Now Drug Product Manufacturing Infocard Summary: Catalent can formulate and fill your product into vial, syringe, or cartridge injectable formats that are ready-to-use (RTU) for the patient or healthcare professional… View Now Evolution of Container Closure Integrity Testing Summary: The USP general chapter “Package Integrity Evaluation – Sterile Product” deeply changes the way it considers the Container Closure Integrity Testing (CCIT) within the pharmaceutical… View Now Expediting Path to Clinic with OptiForm® Total Supply Summary: MGB Biopharma, a biotech company based in Scotland, U.K. was developing a new class of anti-infective medicine based on Minor Groove Binder compounds. Learn how Catalent provided integrated formulation… View Now Primary Packaging Summary: Planning for a clinical supply project? Having a well-thought out packaging design strategy is crucial. Download the eBook today to get expert insights on the best packaging strategies to solve stability and blinding concerns… View Now Managing Risks to Time Critical Product Imports at Clinical Supply Depots Summary: A Catalent customer wanted to run a clinical trial in Israel and was arranging to ship their clinical trial product from a non-Catalent facility in Europe to a Catalent-managed and audited depot in Israel. With the protocol based… View Now Beyond HPLCs: Advanced Analytical Tools for the Development and Analysis of Drug Products Summary: Advanced analytical techniques can provide timely insights into a product’s stability, performance, and composition. Download this webinar to get expert insights on the applications of analytical techniques to help answer various questions… View Now An Integrated Approach to Spray Drying – From Scale-up to Manufacturing Summary: The use of spray drying to manufacture amorphous dispersions is continuing to grow due to the number of drug candidates exhibiting poor solubility. Nearly 40% of the new chemical entities (NCEs) screened by pharmaceutical… View Now Unlock Industry Perspectives on the Advantages and Challenges of Developing Advanced Dosage Forms Summary: Watch the webinar to learn about the tools and technologies for creating dosage forms such as orally disintegrating tablets (ODTs), multi-particulates, and modified release formulations. View Now Strategies To Develop Lipid-Based Drug Delivery Systems And Oral Dosage Forms Summary: Liquid-filled capsules (LFC) are the primary delivery platform for oral delivery of lipid formulations which includes both softgels and liquid-filled hard capsules. Liquid-in-bottle is… View Now Overcoming Manufacturing Challenges For Accelerated Drug Development Summary: It has been reported that surveys of migraine patients have revealed a preference for oral medications with a rapid onset of action that leads to a resolution of their symptoms. Due to the random nature of migraine attacks.. View Now ZYDIS® ODT Unlocks a Patient Preference for Rapid Onset in the Treatment of Migraine Summary: It has been reported that surveys of migraine patients have revealed a preference for oral medications with a rapid onset of action that leads to a resolution of their symptoms. Due to the random nature of migraine attacks.. View Now Why Do New Therapies Succeed Or Fail In The Marketplace? How can decisions made during the preclinical phase of drug development increase the chances of a product’s eventual success in a difficult marketplace? View Now Patient-Focused Drug Design – A View From The R&D Front Lines Summary: Incorporation of patient-focused drug design principles is increasingly becoming essential to ensure that a new drug is commercially successful and delivers the best patient outcomes. View Now Lipid Workshop Part 1: Early Development With Lipids Get insights on using lipid systems during early development to achieve successful formulation and patient outcomes View Now AAPS 2015 Posters Catalent’s experts presented technical posters on advanced drug design, discovery, development, delivery, packaging and scale-up. Click here to download [Part 1] of the 2015 AAPS posters Click here to… View Now Designing Complex Release Oral Solids Controlled and Modified Release dosage form can improve patient experience. View Now Elemental Impurities- Guidelines, Testing And Assessments This eBook published by Pharmaceutical Technology provides an overview of the regulatory landscape related to elemental impurities testing, discusses the challenges of implementing ICH Q3D guidelines … View Now Commercial Scale-Up On Fluid Bed Wurster Coating You will learn about a pharmaceutical company who was interested in scaling-up a multi-particulate, modified-release product to a commercial scale using fluid bed bottom-spray (Wurster) coating. View Now Softgel Technology For Fast-Tracked Development Programs Summary: Given the accelerated timelines associated with expedited programs, lipid-based drug formulations, encapsulated in softgel capsules, provide an attractive option for addressing the challenges… View Now Inhalation Capabilities Sheet Summary: Learn about the end-to-end capabilities of Catalent’s inhalation network, supporting the development and manufacture of formulations delivered by Dry Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs) and unit- or bi-dose nasal sprays. View Now De-Risk Your Early Phase Programs Lipid based drug delivery systems (LBDDS) are the most studied and understood bioavailability enhancing solutions View Now Extractables & Leachables: Understanding Container and Device Interactions Summary: It is vital that drug products reach patients uncontaminated and unadulterated by their packaging. Extractables and leachables (E&L) are especially of concern for liquid injectable… View Now Better Treatments By Design To be successful, new treatments require real-world outcomes for you, your stakeholders, and most importantly the patients. View Now Elemental Impurities- Guidelines, Testing and Assessments Testing for elemental impurities in pharmaceuticals is a key risk assessment activity. This eBook published by Pharmaceutical Technology provides an overview… View Now Overcoming Challenges for Accelerated Development The pharmaceutical industry has experienced a trend in the number of accelerated approval designations for drugs (e.g. orphan drugs, breakthrough therapies, accelerated approvals, and FDA priority reviews) being developed. View Now A View From The R&D Front Lines Incorporation of patient-focused drug design principles is increasingly becoming essential to ensure that a new drug is commercially successful and delivers the best patient outcomes. View Now The Product Development Superhighway Pharmaceutical and biotechnology companies value streamlined services from early-phase development to clinical supply services to commercialization. View Now Formulation Development for Scalability Lipid formulation and spray-dried dispersions are widely used, and proven technologies to overcome bioavailability challenges for poorly soluble molecules. View Now Innovative OTC Remedies for the Seasonal Flu Epidemic We will review the current OTC remedies for cough, cold and allergy categories and discuss strategies to grow your share on shelf space with innovative dosage forms. View Now Is Lipid Based Formulation Best for Your Molecule? Watch this webinar to learn the key considerations for evaluating available technologies to find the most suitable bioavailability solution. View Now Commonly Asked Questions About Elemental Impurities Read the latest article published by Pharmaceutical Technology giving an overview of elemental impurities testing and elemental impurities risk assessment process. View Now Planning Successful Launches Read this article published by Pharmaceutical technology to learn about proven strategies for a successful product launch, including cross-functional team collaboration, risk management and using the right project management tools. View Now Exploring Barriers and Facilitators to Drug Launch Success Understand why new therapies fail or succeed in the market place and learn when and how to apply advanced technologies to help increase the chance of success View Now Sources, Effects, and the Importance of Elemental Impurities for Finished Drug Products Elemental impurities can arise from a variety of sources, such as active pharmaceutical ingredients (API), excipients, manufacturing equipment, and primary container closure systems. View Now Value Creation in the Early Phase Strategies companies can use to succeed in both advancing their candidates and attracting investors View Now Strategies for Solid Form Discovery & Development Solid form screening and selection is an integral part of drug development. View Now De-Risking and Accelerating Oral Drug Development This article outlines the preclinical studies to assess and manage developability risks of NMEs for oral drug products View Now Quality by Design Approach to Analytical Method Optimization Quality by Design (QbD) is well established in the pharmaceutical industry for manufacturing processes, including active pharmaceutical ingredients and drug products. View Now Streamline Early Drug Development How to create a development strategy that bridges gaps earlier in the process to make the transition smoother. View Now The Role of Roller Compaction in Dose Design Roller compaction is a popular dry granulation process with some significant advantages over wet granulation processes. View Now Using Lipid Based Delivery For Early Phase Development Lipid-based drug delivery systems provide a reliable solution for poorly soluble molecules View Now Particle Size Reduction Characterization of the micronized drug is important to understand its bulk properties and design downstream processes and manufacturing approaches. View Now The Truths and Myths of LBDDS Clarifying the myths surrounding LBDSS which may make drug developers consider it in parallel to other formulation approaches View Now Data-Driven Risk Assessment Developers are looking for ways to predict and overcome potential issues of new molecular entities View Now Phase Appropriate Stability Studies Stability is a critical quality attribute of pharmaceutical products View Now Oral Solid Dose Manufacturing Current critical issues facing the oral solid dose manufacturing industry View Now Formulation Design in Oral GLP Toxicology Studies Read this article and learn about focus areas in the early drug development process that are critical for a successful toxicology study. View Now Dysphagia Dose Design Gain more knowledge on dysphagia, which is one of the major factors affecting medication adherence and proper medication administration. View Now Scale-up of Wurster Process Learn more about Wurster Process at Catalent Winchester. View Now Commercial Scale-Up on Fluid Bed Wurster Coating Read this case study on commercial scale-up on fluid bed wurster coating. View Now PBPK Modeling and Other Strategies for Early Phase Success Leveraging knowledge about an API’s physiochemical properties from preformulation and formulation studies increases the chances of early-phase success. View Now Next Generation of Small Molecule Oral Drugs A connected, data-driven approach to managing bioavailability challenges in new chemical entities View Now Pediatric Patient Considerations During Dose Development Developing specific dosing guidelines and acceptable dosage forms for pediatric patients to optimize therapeutic efficacy and limit and prevent serious adverse side effects. View Now Overcoming Technology Transfer Challenges The key to a successful tech transfer is for the vendor and the contract manufacturer to anticipate the challenges and come up with a game plan for the solutions to potential challenges. View Now The Importance of Assessing Elemental Impurities Developing a tailored package of analysis to ensure compliance with regulatory guidelines. View Now Expanding Your OTC Brand Innovative dose forms to expand and improve your product line. View Now Dose Design: Bridging Early- And Late-Phase Development This webcast discusses key concepts that should be addressed as a molecule advances through the clinical development phases View Now Risk Assessment & Test Requirements for Elemental Impurities Selecting the best risk assessment and analytical testing strategy is key to successful compliance with the new regulations. View Now Best Practices for Identifying Development Candidates The use of Pre-clinical tools to study pharmacokinetics, choose a lead drug candidate and move that product into development. View Now Phase Appropriate Stability Studies Regulatory requirements and technical challenges for stability studies vary depending on the phase of the program, the intended market and the product type. View Now Strong Partnership Environment Heralds Success in Pharma Will Downie, Senior Vice President, Global Sales and Marketing at Catalent, explains how his company makes a success of this strategy View Now Putting The Patient First When Manufacturing OSD Forms Expert insights on ODT challenges and solutions from European Pharma Manufacturing. View Now Technical Guide for Solid Dispersion Development Get the steps involved in the development and manufacturing of an ASD via the spray drying process. View Now Pediatric Patient Considerations During Dose Development Learn the key considerations for developing a new drug for pediatric patients. View Now Elemental Impurities in the Pharmaceutical Industry Key insights on guidelines, testing requirements, and analytical approaches for complying with the USP requirements for instrument-based heavy metals testing. View Now The Formulation Complex Tips and advice on overcoming the most common formulation mishaps and why beginning with the end in mind is crucial. View Now From Candidate to Clinic Strategies to Select, Assess, Formulate, and Deliver the Right Drug Candidate in the Early Phase. View Now Dose Selection Using Preclinical PK Modeling How pre-clinical tools used in the industry to study pharmacokinetics are used to guide the development of new chemical entities (NCEs). View Now Delivering the Right Drug Candidate in the Early Phase The key considerations for transitioning a molecule from discovery to Phase 1. View Now Design & Formulation for GLP Toxicology Studies Evaluate critical areas in the drug development process to help ensure a successful toxicology study. View Now Review and Analysis of FDA Approved Drugs Using Lipids A review and quantitative analysis of the molecular properties of approved drugs formulated as lipid systems View Now Overcome Bioavailability Challenges with Lipid Drug Delivery How to apply lipid based formulation and encapsulate in softgel capsules for a poorly soluble molecule. View Now Bioavailability Enhancement Through Spray Dried Dispersions The key spray dried dispersion (SDD) development considerations to enhance and sustain in-vivo drug solubility. View Now Catalent Spray Drying Technology A holistic approach to the development and manufacture spray dried dispersions. View Now Bioavailability Enhancement through Spray Dried Dispersions The key spray dried dispersion (SDD) development considerations to enhance and sustain in-vivo drug solubility. View Now Let the Molecule Decide Each new drug is unique and deserves a fresh approach to formulation. View Now Designing Complex Release Oral Solids Controlled and Modified Release dosage form can improve patient experience. View Now Tech Talks with Catalent – Spray Drying Technology Successful spray drying process for clinical and commercial production. View Now Smart Drug Development & Design from Candidate to Phase I Key considerations for transitioning a molecule from discovery to phase 1 readiness View Now Data-Driven Approach to Overcome Bioavailability Challenges Unbiased & data-driven approach to select bioavailability enhancement technology. View Now Optiform® Solution Suite Quick facts about OptiForm® Solution Suite View Now Customized Manufacturing Customize and unique manufacturing solutions to manufacture your drug. View Now Optimizing Clinical Outcomes for Challenging Molecules How lipid-based drug delivery systems (LBDDS) can be used as a bioavailability enhancing technology. View Now Solid Dose Trends How the industry’s most stable drug form is innovating and evolving to stay relevant. View Now Formulating Candidates with Bioavailability Issues How formulation screening early in the process can reduce development timelines. View Now Optimizing Speed To Market With Flexible Manufacturing Process Get the seven steps to implement a new manufacturing technology. View Now Improve Patient Experience and Therapeutic Outcomes Advanced formulation and drug delivery technologies for patient-centric drug design. View Now Developing Oral Dosage Forms Agnostic & data-driven approach for early stages to find optimal formulation technology View Now The Challenges in Developing Therapeutic Cannabis Development of Cannabis- based drugs can offer a consistent, reliable dose with minimal side effects. View Now Customized Manufacturing Solutions Summary: Manufacturing pharmaceutical, biologic and consumer health products is becoming ever more challenging. With more complex molecules, accelerated timelines, global requirements and regulatory… View Now Expedite Early Drug Development How pre-formulation techniques can accelerate early phase development to PK and first-in-human studies. View Now Orally Disintegrating Tablets- A Patient-Centric Dosage Form Discover how orally disintegrating tablets (ODTs) can be both patient friendly and offer numerous formulation advantages. View Now Importance of Defining & Characterizing Solid State Forms The effect of salt form selection and polymorphic screening on formulation development. View Now Pediatric Drug Delivery Challenges and Solutions Key development challenges and promising technologies for delivering pediatric formulations. View Now Preclinical & First-in-Human Development Strategies Crucial factors to transform a pre-clinical compound into a first-in-human candidate. View Now Oral Delivery of Macromolecule Drugs for Localized Treatment Latest formulation approaches on enabling oral route for macromolecule drugs for local treatment. View Now Early-Phase Pharmaceutical Development Strategies Insight on early development, characterizing solid state forms and first-in-human strategies. View Now Considering Patient’s Voice in Drug Design Strategies on incorporating patient opinion into early drug design and boost patient adherence. View Now Trends in Manufacturing of Specialty Products A guide on creating flexible and custom manufacturing solutions for speciality products. View Now Advances in Manufacturing Technology Technology management approach & process capabilities for reliable supply of drug products. View Now Flexible Manufacturing Gets Pharma Products to Market Faster Designing state-of-the-art facilities and suites address customers’ current and future needs. View Now Strategic Approach for Manufacturing Solid Dosage Forms Unique roller compaction platform designed to achieve clinical and commercial success. View Now Preclinical & First-in-Man Drug Development Strategies Methods for developing a sound, phase-appropriate formulation for early development. View Now Improve Your Phase I Success Rate A parallel formulation feasibility assessment approach to enhance bioavailability. View Now ODT: A Patient-Centric Dosage Form Discover new developments in ODT technology including delivery of peptides and vaccines. View Now Facilities and Operational Investment A systematic approach to tech transfers and how to focus on technical expertise & flexibility. View Now Best of Pharma Manufacturing 2016 Explore the most-read articles from 2016, chosen by the Pharmaceutical Manufacturing audience. View Now Lipid Workshop Part 2: Expanding Lipid Formulation Platform Latest softgel technology for targeted and controlled delivery of challenging molecules. View Now Lipid Workshop Part 1: Early Development With Lipids Softgel technology for early development to achieve successful formulation and patient outcomes. View Now Softgel: Shapes and Sizes Softgel technology has been increasingly applied across a wide range of applications including prescription medicines, consumer health, vitamins & mineral supplements and cosmetics. View Now AAPS 2016 Presentations Discover the latest solutions and advancement in drug delivery technologies. View Now Particle Size Reduction to Improve Drug Performance Create market differentiation and enable products that meet the specific medical needs of individual patients. View Now Improved Bioavailability of Trio Medicines TML-2 Utilize OptiForm Solution Suite to provide options for candidate formulations with extensive supporting data. View Now Brochure: Development Solutions A toolkit of superior technologies to overcome all your molecule’s challenges and processing difficulties to get the optimal dosage form. View Now Overcome Barriers to Non-invasive Delivery Of Macromolecules Innovative, integrated approach to rapidly screen biomolecules potential for oral delivery. View Now A Dosage Form Designed for Difficult Patient Populations Explore how orally disintegrating tablets (ODTs) provide an alternative to overcome several challenges. View Now A Holistic Approach for Drug Development and Delivery How can a patient-centric outlook help scientists tackle the key challenges of early drug development. View Now Advances in Manufacturing Technology Improve the efficiency, reliability, flexibility & speed to market for your next manufacturing process. View Now Thinking Small Enhance bioavailability & efficacy while reducing adverse effects with particle size reduction. View Now New Approaches to De-risking Early Drug Development Insights on how to pick the right candidates for clinical development & revamping projects. View Now Unlock Oral Delivery Potential for Macromolecules Effectively evaluate the potential of peptides and macromolecules for oral delivery. View Now Optimize Dosage Form for Patient-Centric Drug-Development Strategies & technologies which can minimize the risks of developing new drugs and more. View Now Innovative Drug Delivery Technologies for Better Treatments Better patient treatments fueled by innovations in lipid formulations. View Now How Parallel Development with Proven Technologies Improves Efficiently and rapidly overcome complex bioavailability challenges for early stage molecules. View Now Enhance Bioavailability with Parallel Screening Technologies Characterize molecules, apply right prediction model, & select ideal delivery technology. View Now The Soft Side of Drug Delivery Discover an innovative way to deliver challenging and poorly soluble compounds. View Now OptiShell™ Technology for the OTC Market Innovative solution for overcoming encapsulation challenges for OTC products. View Now Patient-centric Dose Design Avoid some of the limitations of conventional tablet dose forms & more. View Now The Versatile Orodispersable Tablet (ODT) Technology ODT platform ideal for sublingual delivery of proteins, peptides & vaccines. View Now LBDDS to Bring Poorly Soluble Drugs to Market Address compounds early on in the development process to reduce costs & attrition rates. View Now Keys to Successful Technology Transfers Ensure your technology transfers meet scheduled timelines. View Now Versatility of Micronization for Bioavailability Enhancement Explores the benefits of co-micronization with a surfactant and cryogenic micronization. View Now Critical Process Parameters of an API via Micronization Understand the logistics of commercial manufacturing using design of experiments (DOE). View Now The Medicine Maker – Bioavailability by Design Address bioavailability challenges faced in biologic development with a focus on oral delivery. View Now Oral Dose Development of Macromolecules Discover new approach to optimize oral dose development for macromolecules. View Now Optimal Formulation Technology for Better Patient Treatment Strategies for oral formulation selection which can lower attrition rates and more. View Now Handling Highly Potent Materials Safely Have a rigorous and carefully designed plan as to how to handle the compounds safely. View Now Graphicaps™ Inline Printing Differentiate products at the unit dose level & deliver a more recognizable product. View Now The Next Generation ODT New developments in ODT technology, including new ways to administer peptides & vaccines. View Now Overcoming Challenges In Generic pMDI Development Define key aspects of product performance which must be met when developing a generic pMDI. View Now Parallel Screening for Non-Invasive Macromolecule Delivery Integrated solutions to rapidly screen biomolecules potential for non-invasive delivery route. View Now Strategies To Overcome Development Challenges Address development challenges early on and improve a drug’s path to market. View Now Accelerate Development for Challenging Compounds Leverage solid dispersion & particle size reduction technology to enhance bioavailability. View Now Roadmap for Successful Technology Transfer Make the right decisions to ensure a successful technology transfer. View Now Holistic Approach To High Potency API Operations Mitigate cross-contamination risk and regulatory issues. View Now Novel Technologies To Deliver Oral Oncology Therapies Select optimal formulation technology to enhance therapeutic performance & patient experience. View Now Optimizing API Properties And Formulation Utilize particle size reduction and formulation technologies to optimize the API. View Now Overcome Formulation Challenges & Gain Customer Acceptance Enhance bioavailability, deliver liquid APIs & more with softgel technology. View Now Softgel Technologies to Deliver Poorly Soluble Molecules Expedite the development pathway for early phase compounds and enhance bioavailability. View Now Create Effective Fast-Dissolving Oral Formulations Successfully manufacture oral dosage forms that disperse within 3 seconds & are enjoyable. View Now Catalent Innovations, Trends and New Technologies Boost bioavailability, improve ease & route of administration, and increase patient compliance. View Now The Medicine Maker – Deep Breaths and Dry Powder Explore the challenges with delivering drugs less invasively. View Now Drug Manufacturing Solutions in a Complex Industry Address unique program requirements with flexible manufacturing solutions. View Now Accelerated Bioavailability for Early Phase Molecules Increase the dissolution rates of poorly water-soluble drugs to increase bioavailability. View Now Addressing Early Phase Development Challenges Increase patient adherence while reducing reformulation time & costs. View Now Novel Coating Process for Taste Masking APIs Provide the ability to taste mask & coat smaller particle size APIs. View Now A Structured Approach to Enhancing Bioavailability Utilize an all-encompassing approach to enable an effective dosage form faster to market. View Now Optimizing Small Batch Size To Solve Formulation Challenges Enable the formulation development of a drug molecule in softgels on industrial scale machines. View Now Enteric Coated Softgels for Consumer Products Improve product performance & enhance consumer experience with enteric coating. View Now The Medicine Maker – Finding Optimal Form Increase chances of success in drug development by focusing on API optimization from the start. View Now Bioavailability Enhancement for Early Phase Molecules Suitable path to accelerate development, avoid risk at early phase & enhance bioavailability. View Now Solution Suite Accelerates Bioavailability Enhancement Select the most suitable formulation technology to enhance the molecule’s bioavailability. View Now The Medicine Maker – Delivering Change The future of non-invasive delivery technologies for large molecules. View Now The Medicine Maker – The Toolbox of 2025 Overcome therapeutic challenges and be prepared for years to come. View Now Oral Formulation Strategies and Technologies Oral dose development with optimal therapeutic performance. View Now Bringing a Small Molecule to Clinic Transition from preliminary formulation to commercial drug launch, quickly & cost-effectively. View Now Softgel Capsules Low Batch Size Optimize in cGMP Labs Handle small amounts of API or formulation at the early stages of development. View Now Optimization of Type I & II Lipid Based Drug Delivery System Limit individual variability of type I & II systems with adequate choice of composition. View Now Pharmaceutical Abuse Deterrent Capsule Formulations Develop liquid capsule fill formulations that are mitigated to prevent abuse. View Now Bioavailability Toolkit to Fast Track Development Design a safe, effective & stable dosage form, and ensure patient compliance. View Now Solutions for Challenging Compounds Using Softgel Innovation Improve compatibility with wider range of excipients to enhance bioavailability & stability. View Now Overcoming Poor Solubility in Formulation Development Lipid-based drug-delivery systems to assist in the delivery of poorly soluble drugs. View Now Overcome Early Phase Development Challenges Perform dosage form selection in the early phases of drug development. View Now The Versatility of Softgel Technology Optimize manufacturing parameters like lower processing temperature & thinner softgel shell. View Now New Approaches for Macromolecule Oral Delivery The toolkit of technologies based upon lipid-based drug delivery systems. View Now New Technologies for Complex Oral Formulation Drug delivery solutions need to become more sophisticated and more effective. View Now Early Technology Selection for Optimized Drug Development Choose the right technology to develop an efficient Phase I enabling drug product View Now Formulation Development with Minimal Amount of API Solubility screening approaches that can save both time and money. View Now The Bioavailability Toolbox Scientists now have an arsenal of drug delivery techniques to choose from. View Now OptiGel Mini Technology Deliver higher API concentrations in smaller capsules for patient benefits. View Now AAPS 2014 with Pharmaceutical Outsourcing OptiPact™ Technology, capabilities for Orphan Drugs & Catalent’s factors of differentiation. View Now OptiGel Bio Enables Delivery of Synthetic Oligosaccharides Macromolecules can potentially be converted from injectable to oral drug delivery. View Now Optimize Your Oral Drug Development Pathway Learn about how softgel technologies can address API and processing challenges. View Now New Formulation and Delivery Technology is Unlocking Profit Learn more about integrating formulation technology in drug development. View Now Lipid-Based Delivery of Peptide Therapeutics An explanation of OptiGel Bio™ technology as a delivery tool for macromolecule NCE candidates. View Now Conversion from LFHS to RP Scherer Softgel Capsules RP Scherer Technology can improve timelines and commercialization potential. View Now Strategies for Orphan, Breakthrough and Fast Track Programs Learn about Orphan drug development and other fast track product development pathways. View Now OptiShell® Technology Capsule Innovations New shell and hot-filling that are highly viscous or semi-solid at room temperature View Now Expert Content Subscribe Investors Careers Contact Us Site Map Follow Us. Share Us. By using this website you understand and accept that Catalent tracks your website activities to be able to offer you a more tailored response or information to meet your requirements, and that your personal data will be held in accordance with our Privacy Policy | Privacy Shield Statement | Cookies Settings. Copyright 2021, Catalent, Inc - All Rights Reserved Terms Modern Slavery Statement This Website Uses Cookies By using this website you understand and accept that Catalent tracks your website activities to be able to offer you a more tailored response or information to meet your requirements, and that your personal data will be held in accordance with our Privacy Policy. Accept All Cookies Cookies Settings